WASHINGTON – The United States receives a third vaccine to prevent COVID-19 after the Food and Drug Administration on Saturday authorized a Johnson & Johnson vaccine that only works with one dose instead of two.
Health experts eagerly await unique option to speed up vaccinations as they race against virus that has already killed more more than 510,000 people in the United States and is undergoing an increasingly disturbing change.
The FDA said J & J’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose protected 85% against the most serious COVID-19 disease in a massive study that spanned three continents – protection that has remained strong even in countries like South Africa, where the most concerning variants are spreading.
“This is really good newsDr. Francis Collins, director of the National Institutes of Health, told The Associated Press on Saturday. “The most important thing we can do right now is get as many hits in as many arms as possible.”
J&J is initially supplying a few million doses and shipments to the states could begin as early as Monday. At the end of March, J&J announced that it plans to deliver 20 million doses to the United States and 100 million by the summer.
J&J is also seeking authorization for the emergency use of its vaccine in Europe and from World Health …
News Highlights Politics
- Headline: Johnson & Johnson Single Dose Vaccine Gets FDA Approval | Politics
- Check all news and articles from the Politics news updates.